2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$31.00+$0.39 (+1.29%)
Price as of Oct 02, 2026 4:45 PM EDT- $1.1BMarket Cap
- -35.87%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$31.00+$0.39 (+1.29%)
Earnings Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 6 |
Momentum Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -12.95% | ||
12-Month Momentum | -23.57% | ||
3-Month Risk Adjusted Momentum | -65.57% | ||
12-Month Risk Adjusted Momentum | -37.59% |
True Yield
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.02% |
Financial Health Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |